47

DAFTAR PUSTAKA

1. Rahman F, Kwan GF, Benjamin EJ. Global epidemiology of atrial

fibrillation. Nat Rev Cardiol. Nature Publishing Group, a division of

Macmillan Publishers Limited. All Rights Reserved.; 2014

Nov;11(11):639–54.

2. Go A, Hylek E, Phillips K. Prevalence of diagnosed atrial fibrillation in

adults. JAMA J Am Med Assoc. 2001;285(18):9;285(18):2370–5.

3. Camm AJ, Kirchhof P, Lip GYH, Schotten U, Savelieva I, Ernst S, et al.

Guidelines for the management of atrial fibrillation: The Task Force for the

Management of Atrial Fibrillation of the European Society of Cardiology

(ESC). Eur Heart J. 2010;31(19):2369–429.

4. Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin

EJ, et al. Worldwide Epidemiology of Atrial Fibrillation: A Global Burden

of Disease 2010 Study. Circulation. 2014;129(8):837–47.

5. Heeringa J. Prevalence, incidence and lifetime risk of atrial fibrillation: the

Rotterdam study. Eur Heart J. 2005;27(8):949–53.

6. Yuniadi Y, Tondas AE, Hanafy DA, Hermanto DY, Maharani E, Munawar

M, et al. Pedoman Tata Laksana Fibrilasi Atrium. 1st ed. Centra

Communications; 2014.

7. Ariansena I, Gjesdala K, Abdelnoorb M, Edvardsenc E, Engerd S, Tveitd

A. Quality of Life , Exercise Capacity and Comorbidity in Old Patients

with Permanent Atrial Fibrillation. J Atr Fibrillation. 2009;1(4):13–20.

8. Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of

the long-term risks associated with atrial fibrillation: 20-year follow-up of

the Renfrew/Paisley study. Am J Med. 2002 Oct;113(5):359–64.

9. Wolf PA, Abbott RD, Kannel WB. Atrial Fibrillation as an Independent

Risk Factor for Stroke : The Framingham Study. Stroke. 1991;22(8):983–8.

48

10. Benjamin EJ D’Agostino RB, Silbershatz H, Kannel WB, Levy D WPA.

Impact of atrial fibrillation on the risk of death: the Framingham Heart

Study. Circulation. 1998;98(10):946–52.

11. Hui DS, Morley JE, Mikolajczak PC, Lee R. Atrial fibrillation: A major

risk factor for cognitive decline. Am Heart J. 2015;169(4):448–56.

12. Gaita F, Corsinovi L, Anselmino M, Raimondo C, Pianelli M, Toso E, et al.

Prevalence of silent cerebral ischemia in paroxysmal and persistent atrial

fibrillation and correlation with cognitive function. J Am Coll Cardiol.

2013;62(21):1990–7.

13. Thacker EL, McKnight B, Psaty BM, Longstreth WT, Sitlani CM, Dublin

S, et al. Atrial fibrillation and cognitive decline: a longitudinal cohort

study. Neurology. 2013 Jul 9;81(2):119–25.

14. Marzona I, O’Donnell M, Teo K. Increased risk of cognitive and functional

decline in patients with atrial fibrillation: results of the ONTARGET and

TRANSCEND studies. Can Med Assoc J. 2012;184(6):E329–36.

15. Costa AS, Fimm B, Friesen P, Soundjock H, Rottschy C, Gross T, et al.

Alternate-form reliability of the Montreal cognitive assessment screening

test in a clinical setting. Dement Geriatr Cogn Disord. 2012;33(6):379–84.

16. Freitas S, Simões MR, Alves L, Vicente M, Santana I. Montreal Cognitive

Assessment (MoCA): Validation Study for Vascular Dementia. J Int

Neuropsychol Soc. 2012;1–10.

17. Dong Y, Lee WY, Basri NA, Collinson SL, Merchant RA,

Venketasubramanian N, et al. The Montreal Cognitive Assessment is

superior to the Mini–Mental State Examination in detecting patients at

higher risk of dementia. Int Psychogeriatrics. 2012;24(11):1749–55.

18. Salam S, Muis A, Aliah A, Akbar M. Association Atrial Fibrillation with

Cognitive Fakultas Kedokteran Universitas Hasanuddin. 2013;0–12.

19. Salehi R, Enamzadeh E, Goldust M. Study of Cognitive Disorder in Stroke-

free Patients with a History of Atrial Fibrillation. Pakistan J Biol Sci.

2013;16(1):44–7.

49

20. Nasution SA, Ranitya R, Ginanjar E. Fibrilasi Atrial. In: Buku Ajar Ilmu

Penyakit Dalam. 6th ed. Interna Publishing; 2014. p. 1365–79.

21. Gehi AK, Mounsey PJ. Atrial Fibrillation. In: Netter’s Cardiology. 2nd ed.

Elsevier Inc; 2010. p. 233–9.

22. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et

al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With

Atrial Fibrillation. Circulation. 2006;114(7):700–52.

23. Jaïs P, Haïssaguerre M, Shah DC, Chouairi S, Gencel L, Hocini M, et al. A

focal source of atrial fibrillation treated by discrete radiofrequency ablation.

Circulation. 1997;95(3):572–6.

24. Takahashi Y, Hocini M, O’Neill MD, Sanders P, Rotter M, Rostock T, et

al. Sites of focal atrial activity characterized by endocardial mapping

during atrial fibrillation. J Am Coll Cardiol. 2006;47(10):2005–12.

25. Tse HF, Lau CP, Kou W, Pelosi F, Oral H, Kim M, et al. Prevalence and

significance of exit block during arrhythmias arising in pulmonary veins. J

Cardiovasc Electrophysiol. 2000;11(4):379–86.

26. Prystowsky EN, J. Padanilam B, L.Waldo A. Atrial Fibrillation, Atrial

Flutter, and Atrial Tachycardia. In: Hurst’s The Heart. 13th ed. The

McGraw-Hill Companies,Inc.; 2011. p. 963–86.

27. Morady F, P.Zipes D. Atrial Fibrillation: Clinical Features, Mechanisms,

and Management. In: Braunwald’s Heart Disease. 10th ed. Elsevier Inc.;

2015. p. 798–813.

28. Benjamin EJ. Independent Risk Factors for Atrial Fibrillation in a

Population-Based Cohort. JAMA. 1994;271(11):840.

29. Schoonderwoerd BA, Smit MD, Pen L, Van Gelder IC. New risk factors

for atrial fibrillation: causes of “not-so-lone atrial fibrillation.” Europace.

2008;10(6):668–73.

30. Kirchhof P, Lip GYH, Van Gelder IC, Bax J, Hylek E, Kääb S, et al.

Comprehensive risk reduction in patients with atrial fibrillation: Emerging

50

diagnostic and therapeutic options. Executive summary of the report from

the 3rd AFNET/EHRA consensus conference. Thromb Haemost.

2011;106(6):1012–9.

31. Friberg L, Hammar N, Rosenqvist M. Stroke in paroxysmal atrial

fibrillation: Report from the Stockholm Cohort of Atrial Fibrillation. Eur

Heart J. 2010;31(8):967–75.

32. Camm AJ, Lip GYH, De Caterina R, Savelieva I, Atar D, Hohnloser SH, et

al. 2012 focused update of the ESC Guidelines for the management of atrial

fibrillation. Eur Heart J. 2012;33(21):2719–47.

33. Hylek EM, Go AS, Chang Y, Jensvold NG, Henault LE, Selby J V, et al.

Effect of intensity of oral anticoagulation on stroke severity and mortality

in atrial fibrillation. N Engl J Med. 2003;349(11):1019–26.

34. Gillis AM, Verma A, Talajic M, Nattel S, Dorian P. Canadian

Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm

management. Can J Cardiol. 2011;27:47–59.

35. Olesen JB, Torp-Pedersen C, Hansen ML, Lip GY. The value of the

CHA2DS2-VASc score for refining stroke risk stratification in patients

with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort

study. Thromb Haemost. 2012;107(6):1172–9.

36. Olesen JB, Lip GYH, Hansen ML, Hansen PR, Tolstrup JS, Lindhardsen J,

et al. Validation of risk stratification schemes for predicting stroke and

thromboembolism in patients with atrial fibrillation: nationwide cohort

study. BMJ. 2011;342(jan31 1):d124.

37. Friberg L, Rosenqvist M, Lip GYH. Evaluation of risk stratification

schemes for ischaemic stroke and bleeding in 182 678 patients with atrial

fibrillation: The Swedish Atrial Fibrillation cohort study. Eur Heart J.

2012;33(12):1500–10.

38. Pisters R, Lane D a, Nieuwlaat R, de Vos CB, Crijns HJGM, Lip GYH. A

novel user-friendly score (HAS-BLED) to assess one-year risk of major

bleeding in atrial fibrillation patients: The Euro Heart Survey. Chest.

2010;1093–100.

51

39. Gallego P, Roldán V, Torregrosa JM, Gálvez J, Valdés M, Vicente V, et al.

Relation of the HAS-BLED bleeding risk score to major bleeding,

cardiovascular events, and mortality in anticoagulated patients with atrial

fibrillation. Circ Arrhythm Electrophysiol. 2012;5(2):312–8.

40. Harris P, Nagy S, Vardaxis N. Mosby’s Dictionary of Medicine, Nursing

and Health Professions. Training. 2010. 2072 p.

41. Glisky EL. Changes in Cognitive Function in Human Aging. CRC

Press/Taylor & Francis; 2007.

42. Zabar Y, Danay P, Macaulay C. Cognitive and Language Evaluation. In:

Netter’s Neurology. 2nd ed. Elsevier Inc; 2011. p. 31–50.

43. Satyanegara. Ilmu Bedah Saraf Satyanegara. 4th ed. Gramedia Pustaka

Utama; 2010.

44. Nolen-Hoeksema S, Fredrickson B, Loftus G. Atkinson & Hilgard’s

Introduction to Psychology. Cengage Learning. 2009. 800 p.

45. Ropper AH, Samuels MA, Klein JP. Dementia, the Amnestic Syndrome,

and the Neurology of Intelligence and Memory. In: Adams & Victor’s

Principles of Neurology. 10th ed. McGraw-Hill; 2014. p. 434–54.

46. Zabar Y. Dementia: Mild Cognitive Impairment, Alzheimer Disease, Lewy

Body Dementia, Frontotemporal Lobar Dementia, Vascular Dementia. In:

Netter’s Neurology. 2nd ed. Elsevier Inc.; 2011. p. 219–43.

47. About | MoCA Montreal - Cognitive Assessment [Internet]. [cited 2016 Jan

9]. Available from: http://www.mocatest.org/

48. Shea S, Di Tullio M. Atrial fibrillation, silent cerebral ischemia, and

cognitive function. J Am Coll Cardiol. Elsevier Inc; 2013;62(21):1998–9.

49. O’Connell JE, Gray CS, French JM, Robertson IH. Atrial fibrillation and

cognitive function: case-control study. J Neurol Neurosurg Psychiatry.

1998;65(3):386–9.

52

50. Dublin S, Anderson ML, Heckbert SR, Hubbard RA, Sonnen JA, Crane

PK, et al. Neuropathologic changes associated with atrial fibrillation in a

population-based autopsy cohort. J Gerontol A Biol Sci Med Sci.

2014;69(5):609–15.

51. Duron E, Hanon O. Vascular risk factors, cognitive decline, and dementia.

Vasc Health Risk Manag. 2008;4(2):363–81.

52. O’Sullivan M. Leukoaraiosis. Pract Neurol. 2008;8(1):26–38.

53. Caplan LR, Hennerici M. Impaired clearance of emboli (washout) is an

important link between hypoperfusion, embolism, and ischemic stroke.

Arch Neurol. 1998;55(11):1475–82.

54. Lip GYH, Bawden L, Hodson R, Rutland E, Snatchfold J, Beevers DG.

Atrial fibrillation amongst the Indo-Asian general practice population. The

West Birmingham Atrial Fibrillation Project. Int J Cardiol.

1998;65(2):187–92.

55. Ball J, Carrington MJ, Stewart S. Mild cognitive impairment in high-risk

patients with chronic atrial fibrillation: a forgotten component of clinical

management? Heart. 2013;99(8):542–7.

56. Wadley VG, McClure LA, Howard VJ, Unverzagt FW, Go RC, Moy CS, et

al. Cognitive status, stroke symptom reports, and modifiable risk factors

among individuals with no diagnosis of stroke or transient ischemic attack

in the REasons for Geographic and Racial Differences in Stroke

(REGARDS) study. Stroke. 2007;38(4):1143–7.

57. Alosco ML, Spitznagel MB, Sweet LH, Josephson R, Hughes J, Gunstad J.

Atrial fibrillation exacerbates cognitive dysfunction and cerebral perfusion

in heart failure. PACE - Pacing Clin Electrophysiol. 2015;38(2):178–86.

58. Forti P, Maioli F, Pisacane N, Rietti E, Montesi F, Ravaglia G. Atrial

fibrillation and risk of dementia in non-demented elderly subjects with and

without mild cognitive impairment (MCI). ArchGerontolGeriatr. 2007;44

Suppl 1:155–65.

53

Lampiran 1. Ethical Clearance

54

Lampiran 2. Surat Izin Penelitian

55

Lampiran 3. Informed Consent

56

57

Lampiran 4. Lembar MoCA-Ina

58

Lampiran 5. Data Subjek Penelitian

No Nama Jenis

Kelamin

Umur Pendidikan

Terakhir

Status Skor Intepretasi

Skor

1 Nur P 49 SD af 16 Menurun

2 Mus P 36 SMA af 25 Menurun

3 Wah L 45 SMA af 24 Menurun

4 Kev L 18 SMA sinus 30 Normal

5 Ras L 37 SMP af 23 Menurun

6 Sum L 54 SMA af 24 Menurun

7 Sub L 47 SMA sinus 29 Normal

8 Kar P 53 Tidak af 15 Menurun

9 Suh P 38 SMP af 26 Normal

10 Mia P 34 SMP af 19 Menurun

11 Tri L 25 SMA sinus 30 Normal

12 Tim L 49 Sarjana sinus 23 Menurun

13 Ain P 61 Sarjana af 24 Menurun

14 Asr L 41 SMA af 24 Menurun

15 Suka L 53 SMP sinus 26 Normal

16 End P 43 Sarjana sinus 27 Normal

17 Jum P 32 SMA af 21 Menurun

18 Ste L 61 sarjana af 24 Menurun

19 Suw L 59 SMA sinus 30 Normal

20 Agu L 49 SMA sinus 30 Normal

21 Mut P 21 SMA sinus 30 Normal

22 Suke L 45 SMA sinus 25 Menurun

23 Eti P 39 SMA sinus 25 Menurun

24 Sla L 53 SMP sinus 26 Normal

25 Asa L 52 Sarjana sinus 29 Normal

26 Mah L 39 SMA sinus 27 Normal

27 Suk L 27 SMA af 25 Menurun

28 Sun L 59 SMA af 22 Menurun

59

Lampiran 6. Uji Statistik SPSS

JenisKelamin

Frequency Percent Valid Percent Cumulative

Percent

Valid

Laki-laki 18 64,3 64,3 64,3

Perempuan 10 35,7 35,7 100,0

Total 28 100,0 100,0

Descriptive Statistics

N Minimum Maximum Mean Std. Deviation

Umur 28 18 61 43,54 11,899

Valid N (listwise) 28

Pendidikan

Frequency Percent Valid Percent Cumulative

Percent

Valid

Sarjana 5 17,9 17,9 17,9

SD 1 3,6 3,6 21,4

SMA 16 57,1 57,1 78,6

SMP 5 17,9 17,9 96,4

Tidak Sekolah 1 3,6 3,6 100,0

Total 28 100,0 100,0

JenisKelamin * Status Crosstabulation

Count

Status Total

Sinus Fibrilasi Atrium

JenisKelamin Laki-laki 11 7 18

Perempuan 3 7 10

Total 14 14 28

60

Pendidikan * Status Crosstabulation

Count

Status Total

Sinus Fibrilasi Atrium

Pendidikan

Sarjana 3 2 5

SD 0 1 1

SMA 9 7 16

SMP 2 3 5

Tidak Sekolah 0 1 1

Total 14 14 28

Status * Intepretasi Crosstabulation

Count

Intepretasi Total

Normal Menurun

Status Sinus 11 3 14

Fibrilasi Atrium 1 13 14

Total 12 16 28

Chi-Square Tests

Value df Asymp. Sig.

(2-sided)

Exact Sig.

(2-sided)

Exact Sig.

(1-sided)

Pearson Chi-Square 14,583a 1 ,000

Continuity Correctionb 11,813 1 ,001

Likelihood Ratio 16,490 1 ,000

Fisher's Exact Test ,000 ,000

Linear-by-Linear Association 14,063 1 ,000

N of Valid Cases 28

a. 0 cells (,0%) have expected count less than 5. The minimum expected count is 6,00.

b. Computed only for a 2x2 table

61

Risk Estimate

Value 95% Confidence Interval

Lower Upper

Odds Ratio for Status

(Sinus / Fibrilasi Atrium)

47,667 4,318 526,168

For cohort Intepretasi =

Normal

11,000 1,632 74,164

For cohort Intepretasi =

Menurun

,231 ,084 ,636

N of Valid Cases 28

62

Lampiran 7. Biodata Mahasiswa

Identitas

Nama : Rofat Askoro Bimandoko

NIM : 22010112130204

Tempat/tanggal lahir : Jakarta / 22 April 1995

Jenis kelamin : Laki-Laki

Alamat : Jalan Platuk Bawang, No.15, Kerten, Laweyan, Surakarta

Nomor HP : 081804453222

e-mail : rofataskoro@gmail.com

Riwayat Pendidikan Formal

1. SD : SD Muhammadiyah 1 Surakarta Lulus tahun:2006

2. SMP : SMP Negeri 1 Surakarta Lulus tahun:2010

3. SMA : SMA Negeri 1 Surakarta Lulus tahun:2012

4. FK UNDIP : Masuk tahun : 2012

63

Lampiran 8. Dokumentasi Penelitian